Warby Parker (WRBY) Shares Outstanding (Weighted Average) (2020 - 2026)
Warby Parker (WRBY) reported Shares Outstanding (Weighted Average) of $123.4 million for Q1 2026, up 1.22% on a YoY basis from $121.9 million in Q1 2025, and up 0.63% quarter-over-quarter from $122.7 million in Q4 2025.
Warby Parker (WRBY) Shares Outstanding (Weighted Average) (2020 - 2026) Analysis & Trends
Warby Parker has reported Shares Outstanding (Weighted Average) for 7 years, with the latest figure at $123.4 million in Q1 2026.
- For the quarter ending Q1 2026, Shares Outstanding (Weighted Average) rose 1.22% year-over-year to $123.4 million; the trailing twelve-month figure through Mar 2026 stood at $123.4 million (up 1.22% YoY), and the FY2025 full-year result was $122.7 million, up 1.9% from the prior year.
- Shares Outstanding (Weighted Average) for Q1 2026 stood at $123.4 million, up from $122.7 million in the prior quarter.
- The five-year high for Shares Outstanding (Weighted Average) was $123.4 million in Q1 2026, with the low at $114.1 million in Q1 2022.
- Historically, Shares Outstanding (Weighted Average) has averaged $118.8 million across 5 years, with a median of $119.1 million in 2024.
- Annual changes were most pronounced in 2022 — Shares Outstanding (Weighted Average) soared 111.76% — and 2026, when it climbed 1.22%.
- Warby Parker's Shares Outstanding (Weighted Average) stood at $114.9 million in 2022, then increased by 2.13% to $117.4 million in 2023, then increased by 2.55% to $120.4 million in 2024, then grew by 1.9% to $122.7 million in 2025, then grew by 0.63% to $123.4 million in 2026.
- The last three Shares Outstanding (Weighted Average) figures came in at $123.4 million (Q1 2026), $122.7 million (Q4 2025), and $123.0 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares (Weighted Avg.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn | 354.90 Mn |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn | 283.14 Mn |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn | 819.00 Mn |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn | 145.34 Mn |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn | 72.00 Mn |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn | 174.20 Mn |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn | 195.40 Mn |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn | 71.43 Mn |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn | 515.00 Mn |
| 10 | Warby Parker | 3.11 Bn | 2.82 Bn | 131.04 Mn | 123.44 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 123.44 Mn |
| Dec 31, 2025 | 122.67 Mn |
| Sep 30, 2025 | 122.96 Mn |
| Jun 30, 2025 | 122.57 Mn |
| Mar 31, 2025 | 121.95 Mn |
| Dec 31, 2024 | 120.39 Mn |
| Sep 30, 2024 | 120.04 Mn |
| Jun 30, 2024 | 120.09 Mn |
| Mar 31, 2024 | 119.14 Mn |
| Dec 31, 2023 | 117.39 Mn |
| Sep 30, 2023 | 117.00 Mn |
| Jun 30, 2023 | 116.48 Mn |
| Mar 31, 2023 | 116.16 Mn |
| Dec 31, 2022 | 114.94 Mn |
| Sep 30, 2022 | 115.25 Mn |
| Jun 30, 2022 | 114.39 Mn |
| Mar 31, 2022 | 114.10 Mn |
| Dec 31, 2021 | 71.25 Mn |
| Sep 30, 2021 | 56.99 Mn |
| Jun 30, 2021 | 54.02 Mn |